X |
Filing Date |
Trade Date |
Ticker |
Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2026-08-04 | MBX | Azoulay Salomon | Chief Medical Officer | S - Sale | $65.77 | -370 | 14,399 | -3% | -$24,335 | ||||||
| D | 2026-05-08 | MBX | Azoulay Salomon | Chief Medical Officer | S - Sale+OE | $38.36 | -70,003 | 14,769 | -83% | -$2,685,515 | |||||
2026-05-06 | MBX | Azoulay Salomon | Chief Medical Officer | S - Sale | $29.54 | -231 | 14,769 | -2% | -$6,824 | ||||||
2026-05-06 | MBX | Hawryluk P. Kent | Pres, CEO | S - Sale | $29.54 | -607 | 1,214,444 | 0% | -$17,931 | ||||||
2026-03-13 | MBX | Hawryluk P. Kent | Pres, CEO | P - Purchase | $28.41 | +18,500 | 1,215,051 | +2% | +$525,663 | ||||||
2025-10-20 | MBX | Hawryluk P. Kent | Pres, CEO | P - Purchase | $13.64 | +20,000 | 949,674 | +2% | +$272,790 | ||||||
2025-10-17 | MBX | Hoerter Steven L. | Dir | P - Purchase | $13.25 | +20,000 | 20,000 | New | +$264,984 | ||||||
2025-09-26 | MBX | Heron Patrick J | Dir, 10% | P - Purchase | $18.00 | +666,666 | 5,219,440 | +15% | +$11,999,988 | ||||||
2025-04-08 | MBX | Pescovitz Ora H. | Dir | P - Purchase | $5.89 | +7,693 | 24,329 | +46% | +$45,312 | ||||||
| M | 2025-02-14 | MBX | Gordon Carl L | Dir, 10% | P - Purchase | $10.60 | +190,672 | 747,887 | +34% | +$2,020,756 | |||||
| M | 2025-02-14 | MBX | Orbimed Advisors LLC | Dir, 10% | P - Purchase | $10.60 | +190,672 | 747,887 | +34% | +$2,020,756 | |||||
| D | 2025-02-04 | MBX | Hawryluk P. Kent | Pres, CEO | P - Purchase | $10.69 | +50,000 | 929,674 | +6% | +$534,500 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |